Medicare beneficiaries face confusion during the Annual Enrollment Period, with significant plan changes ahead for 2026.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Panelists discuss how the GALAXI-2 and GALAXI-3 trials represented a landmark study design for Crohn’s disease research ...

Researchers say ophthalmologists and optometrists were motivated, at least in part, to use the sutureless grafts for dry eye disease by the profit margin they make on devices.

Researchers in one study found that semaglutide may indirectly improve adherence to antipsychotic therapy for those with ...

An engineered CD40 antibody that can bind to a specific immune receptor and directly injected into tumors has demonstrated in a phase 1 trial that it can trigger a systemic immune response.

Older adults living with HIV face higher rates of opioid prescribing and opioid use disorder than their HIV-negative peers, according to new research from Rutgers University.

Panelists discuss how the GALAXI trials enrolled a broadly generalizable population of adults with moderate to severe Crohn’s disease (CDAI 220-450) requiring objective evidence of active inflammation ...

The differing regulation of key fibrotic pathways suggest that idiopathic pulmonary fibrosis involves dysregulation rather ...

Zoryve cream gains FDA approval for treating mild to moderate atopic dermatitis in young children, offering a safe, ...

Repatha (evolucumab) is now avaliable at a discounted cash price through Amgen's new direct-to-patient program, AmgenNow, and ...